Stanislav Panov

I am a PhD, Professor, and Senior Intensivist at the Military Clinical Hospital (Ministry of Defense of Kazakhstan), specializing in clinical toxicology and extracorporeal detoxification. My research focus is the transition from classical immunology to precision mitochondrial medicine.

I have developed and validated the concept of the "Mitochondrial Conglomerate" (Mito-Passport technology). My approach shifts the diagnostic focus from isolated organelles to the assessment of the mitochondrial network as a unified, dynamic functional system within immune cells.

Proven Impact:

• Mortality Reduction: Implementation of our mitochondrial-guided protocols in regional oncology led to a 26.7% decrease in mortality (Mangistau region project).

• Toxicity Control: My RCTs demonstrated a 40% reduction in chemotherapy toxicity through targeted mitochondrial boosting.

• Innovation: My latest 2026 research defines the comparative dynamics of neutrophil mitochondrial activity, offering a new blueprint for immune-metabolic rehabilitation.

What I bring to an MSCA Network: As an industrial partner (Mitolab), I offer access to a unique clinical environment (ICU and Extracorporeal Detoxification Unit), a large-scale database of validated oncological cases, and a proprietary methodology for mitochondrial network analysis. I am eager to collaborate with European academic centers to scale these innovations and train the next generation of researchers in mitochondrial health and longevity.